BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16601840)

  • 1. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.
    Hoffmann J; Alt A; Lin J; Lochnit G; Schubert U; Schleicher E; Chavakis T; Brownlee M; Van der Woude FJ; Preissner KT; Hammes HP
    Thromb Haemost; 2006 Apr; 95(4):689-95. PubMed ID: 16601840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericytes and the pathogenesis of diabetic retinopathy.
    Hammes HP
    Horm Metab Res; 2005 Apr; 37 Suppl 1():39-43. PubMed ID: 15918109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.
    Hammes HP; Klinzing I; Wiegand S; Bretzel RG; Cohen AM; Federlin K
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2092-6. PubMed ID: 8491559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
    Yang R; Liu H; Williams I; Chaqour B
    Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
    Luo D; Fan Y; Xu X
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4386-90. PubMed ID: 22627042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
    Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
    Kowluru RA; Menon B; Gierhart DL
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
    Chung HK; Choi SM; Ahn BO; Kwak HH; Kim JH; Kim WB
    Arzneimittelforschung; 2005; 55(10):573-80. PubMed ID: 16294503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
    Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
    Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.
    Cai J; Kehoe O; Smith GM; Hykin P; Boulton ME
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2163-71. PubMed ID: 18436850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin translocation in retinal pericytes during free-radical induced apoptosis.
    Shojaee N; Patton WF; Hechtman HB; Shepro D
    J Cell Biochem; 1999 Oct; 75(1):118-29. PubMed ID: 10462710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.